About CuroVax-Jiangsu CuroVax Co., Ltd.

Language
- 中文
- English

About CuroVax

Home page

CuroVax

Committed to becoming an influential vaccine company with creativity and ingenuity

CuroVax, a national high-tech company, is situated in Changzhou City, Jiangsu Province, China. Spanning a total area of 50,000 square meters, CuroVax facility boasts a substantial building area of 41,000 square meters, which includes a dedicated purification zone spanning 20,000 square meters. We process full-cycle capabilities to independently develop, manufacture and commercialize various vaccines. Our state-of-the-art facilities are equipped to the highest standards, featuring independent virus vaccine production workshops, R&D laboratories, quality control laboratories and animal experiment centers.

As a company dedicated to being innovation-driven, CuroVax not only proceed with independent R&D but also with synergistic collaboration research. We have well established multiple research platforms including large-scale mammalian cell culture, large-scale antigen purification, vaccine testing and quality research, and mRNA vaccine development. Aiming to increase our competitiveness, we constantly to strengthen our research capabilities and diversify our pipeline.

Curovax is steadfast in its commitment a to emerge as a prominent and pioneering vaccine company. Rooted in the mission to care for health and life, we uphold a core set of the values emphasizing unwavering integrity, collaborative co-creating and a resolute pursuit of excellence. It is through these guiding principles that we strive to develop and deliver safe and efficacious vaccine products to benefit individuals worldwide.